PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 77 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $643,000 | 0.0% | 91,144 | 0.0% | 0.02% | +66.7% |
| Q4 2019 | $643,000 | -41.3% | 91,144 | 0.0% | 0.01% | -40.0% |
| Q3 2019 | $1,095,000 | -0.8% | 91,144 | 0.0% | 0.02% | +7.1% |
| Q2 2019 | $1,104,000 | -27.7% | 91,144 | -24.9% | 0.01% | -26.3% |
| Q1 2019 | $1,526,000 | +164.9% | 121,400 | +41.8% | 0.02% | +137.5% |
| Q4 2018 | $576,000 | -34.6% | 85,600 | 0.0% | 0.01% | -11.1% |
| Q3 2018 | $881,000 | +159.1% | 85,600 | +69.2% | 0.01% | +200.0% |
| Q2 2018 | $340,000 | +1.5% | 50,600 | +29.7% | 0.00% | -25.0% |
| Q1 2018 | $335,000 | -58.7% | 39,000 | 0.0% | 0.00% | -55.6% |
| Q4 2017 | $811,000 | +17.7% | 39,000 | 0.0% | 0.01% | +12.5% |
| Q3 2017 | $689,000 | – | 39,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |